144 related articles for article (PubMed ID: 1193726)
1. Enhanced resistance to Corynebacterium pseudotuberculosis infections associated with reduced serum immunoglobulin levels in levamisole-treated mice.
Irwin MR; Knight HD
Infect Immun; 1975 Nov; 12(5):1098-103. PubMed ID: 1193726
[TBL] [Abstract][Full Text] [Related]
2. Effect of levamisole on immunity to Corynebacterium pseudotuberculosis in mice and sheep.
Cameron CM
Onderstepoort J Vet Res; 1977 Mar; 44(1):47-8. PubMed ID: 614519
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of Corynebacterium pseudotuberculosis and the effect of adjuvants in mice.
Brogden KA; Cutlip RC; Lehmkuhl HD
J Comp Pathol; 1985 Apr; 95(2):167-73. PubMed ID: 3837788
[TBL] [Abstract][Full Text] [Related]
4. Cellular and humoral immune responses in sheep experimentally injected with killed and live Corynebacterium pseudotuberculosis.
Garg DN; Chandiramani NK
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Aug; 260(1):117-25. PubMed ID: 4060919
[TBL] [Abstract][Full Text] [Related]
5. Corynebacterium pseudotuberculosis infection in goats. VIII. The effect of vaccination against experimental infection.
Holstad G; Teige J; Larsen HJ
Acta Vet Scand; 1989; 30(3):275-83. PubMed ID: 2629504
[TBL] [Abstract][Full Text] [Related]
6. CORYNEBACTERIAL PSEUDOTUBERCULOSIS IN MICE. II. ACTIVATION OF NATURAL AND EXPERIMENTAL LATENT INFECTIONS.
FAUVE RM; PIERCE-CHASE CH; DUBOS R
J Exp Med; 1964 Aug; 120(2):283-304. PubMed ID: 14208250
[TBL] [Abstract][Full Text] [Related]
7. Immunity to Corynebacterium pseudotuberculosis.
Cameron CM
J S Afr Vet Med Assoc; 1972 Dec; 43(4):343-9. PubMed ID: 4598668
[No Abstract] [Full Text] [Related]
8. Measurements of humoral immunity during treatment with levamisole in rheumatoid arthritis--a review.
Vischer TL
J Rheumatol Suppl; 1978; 4():49-53. PubMed ID: 282446
[TBL] [Abstract][Full Text] [Related]
9. Clinical, humoral, and pathologic findings in adult alpacas with experimentally induced Corynebacterium pseudotuberculosis infection.
Braga WU; Chavera AE; González AE
Am J Vet Res; 2006 Sep; 67(9):1570-4. PubMed ID: 16948603
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Corynebacterium pseudotuberculosis bacterin for the immunologic protection of sheep against development of caseous lymphadenitis.
LeaMaster BR; Shen DT; Gorham JR; Leathers CW; Wells HD
Am J Vet Res; 1987 May; 48(5):869-72. PubMed ID: 3592392
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular immune responses in mice against secreted and somatic antigens from a Corynebacterium pseudotuberculosis attenuated strain: Immune response against a C. pseudotuberculosis strain.
Vale VL; Silva Mda C; de Souza AP; Trindade SC; de Moura-Costa LF; Dos Santos-Lima EK; Nascimento IL; Cardoso HS; Marques Ede J; Paule BJ; Nascimento RJ
BMC Vet Res; 2016 Sep; 12(1):195. PubMed ID: 27608632
[TBL] [Abstract][Full Text] [Related]
12. Experimental Corynebacterium pseudotuberculosis primary infection in goats: kinetics of IgG and interferon-gamma production, IgG avidity and antigen recognition by Western blotting.
Paule BJ; Azevedo V; Regis LF; Carminati R; Bahia CR; Vale VL; Moura-Costa LF; Freire SM; Nascimento I; Schaer R; Goes AM; Meyer R
Vet Immunol Immunopathol; 2003 Dec; 96(3-4):129-39. PubMed ID: 14592726
[TBL] [Abstract][Full Text] [Related]
13. Immunological events in the popliteal lymph node of sheep following injection of liver or killed Corynebacterium ovis into an afferent popliteal lymphatic duct.
Husband AJ; Watson DL
Res Vet Sci; 1977 Jan; 22(1):105-12. PubMed ID: 557223
[TBL] [Abstract][Full Text] [Related]
14. Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain.
Droppa-Almeida D; Vivas WL; Silva KK; Rezende AF; Simionatto S; Meyer R; Lima-Verde IB; Delagostin O; Borsuk S; Padilha FF
Vaccine; 2016 Feb; 34(8):1091-6. PubMed ID: 26796140
[TBL] [Abstract][Full Text] [Related]
15. Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
Silva MTO; Bezerra FSB; de Pinho RB; Begnini KR; Seixas FK; Collares T; Portela RD; Azevedo V; Dellagostin O; Borsuk S
Vaccine; 2018 Jan; 36(1):74-83. PubMed ID: 29174312
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a commercially available vaccine against Corynebacterium pseudotuberculosis for use in sheep.
Piontkowski MD; Shivvers DW
J Am Vet Med Assoc; 1998 Jun; 212(11):1765-8. PubMed ID: 9621886
[TBL] [Abstract][Full Text] [Related]
17. Complement receptor type 3 plays an important role in development of protective immunity to primary and secondary Corynebacterium pseudotuberculosis infection in mice.
Lan DT; Makino S; Shirahata T; Yamada M; Nakane A
Microbiol Immunol; 1999; 43(12):1103-6. PubMed ID: 10656178
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune responses of a murine model against Corynebacterium pseudotuberculosis antigens.
El-Enbaawy MI; Saad MM; Selim SA
Egypt J Immunol; 2005; 12(2):13-9. PubMed ID: 17977206
[TBL] [Abstract][Full Text] [Related]
19. Differential antibody responses to Corynebacterium pseudotuberculosis in sheep with naturally acquired caseous lymphadenitis.
Ellis JA; Hawk DA; Holler LD; Mills KW; Pratt DL
J Am Vet Med Assoc; 1990 May; 196(10):1609-13. PubMed ID: 2189849
[TBL] [Abstract][Full Text] [Related]
20. Aspects of pathogenesis in a mouse model of infection by Corynebacterium pseudotuberculosis.
Batey RG
Aust J Exp Biol Med Sci; 1986 Jun; 64 ( Pt 3)():237-49. PubMed ID: 3767763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
